Dipeptidyl Peptidase 4 Inhibitor [EPC]: Side Effects & Safety Data for 4 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Dipeptidyl Peptidase 4 Inhibitor [EPC] includes 4 drugs with a combined 31,519 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
4
Drugs in Class
31,519
Combined Reports
All Dipeptidyl Peptidase 4 Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| SITAGLIPTIN | JANUVIA | 19,904 | 2,412 | 6,668 | 12.1% |
| LINAGLIPTIN | Linagliptin and metformin hydrochloride | 7,762 | 726 | 2,794 | 9.4% |
| SAXAGLIPTIN | SAXAGLIPTIN | 2,468 | 263 | 838 | 10.7% |
| ALOGLIPTIN | Alogliptin and Pioglitazone | 1,385 | 122 | 567 | 8.8% |
Common Side Effects in Dipeptidyl Peptidase 4 Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Blood glucose increased | 2,411 | 48 |
| Nausea | 1,634 | 86 |
| Drug ineffective | 1,464 | 79 |
| Diarrhoea | 1,354 | 90 |
| Pancreatic carcinoma | 1,301 | 790 |
| Pancreatitis | 1,274 | 191 |
| Dizziness | 1,198 | 54 |
| Product dose omission issue | 1,147 | 1 |
| Vomiting | 1,122 | 80 |
| Headache | 1,119 | 58 |